ObsEva SA to Participate in JP Morgan Virtual Healthcare Conference January 11 - 14, 2021
Geneva, Switzerland and Boston, MA – January 7, 2021 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that Company Management will be participating in the JP Morgan Virtual Healthcare Conference taking place January 11-14, 2021. ObsEva will present on Thursday, January 14, 2021 at 7:30 a.m. Eastern Time (ET).
The presentation webcast will be available in the “Investors” section of ObsEva’s website www.ObsEva.com.
ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids and preterm labor. ObsEva is listed on the NASDAQ Global Select Market and is trading under the ticker symbol "OBSV" and on the SIX Swiss Exchange where it is trading under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com.
For further information, please contact:
CEO Office Contact:
+41 22 552 1550
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
AkzoNobel NV18.1.2021 08:01:58 CET | Press release
AkzoNobel proposes to acquire Tikkurila for €31.25 per share, to create superior and sustainable value for all stakeholders
Subsea 7 (Uk Service Co) Ltd18.1.2021 08:01:58 CET | Press release
Subsea 7 announces changes to Board responsibilities
Agillic A/S18.1.2021 08:01:57 CET | Press release
Reporting of transactions related to shares in Agillic A/S made by persons with managerial responsibilities
Khondrion18.1.2021 08:01:57 CET | Press release
Khondrion receives EMA agreement on its Paediatric Investigation Plan for sonlicromanol
Orion Oyj18.1.2021 08:01:57 CET | Press release
Orion Animal Health and Vetoquinol expand collaboration – Vetoquinol to distribute Orion’s Clevor® in the USA and Orion to distribute Drontal® and Profender® products in Finland, Hungary and Romania
Equinor ASA18.1.2021 07:46:49 CET | Press release
Equinor ASA: Notifiable trading
BW Energy Limited18.1.2021 07:31:48 CET | Press release
BW Energy: Q4 2020 trading update
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom